"Hyaluronan Receptors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Acidic sulfated integral membrane glycoproteins expressed in several alternatively spliced and variable glycosylated forms on a wide variety of cell types including mature T-cells, B-cells, medullary THYMOCYTES; GRANULOCYTES; MACROPHAGES; erythrocytes, and fibroblasts. Their interaction with HYALURONIC ACID mediates binding of lymphocytes to high endothelial VENULES.
| Descriptor ID |
D018960
|
| MeSH Number(s) |
D09.698.735.200.625 D12.776.395.550.200.625.144 D12.776.395.650.750.281 D12.776.543.550.200.625.144 D12.776.543.750.705.877.144 D23.050.301.350.625.144
|
| Concept/Terms |
Hyaluronan Receptors- Hyaluronan Receptors
- Hyaluronic Acid Binding Protein
- Hyaluronan-Binding Protein
- Hyaluronan Binding Protein
- CD44 Antigen
- Antigen, CD44
- Receptors, Hyaluronan
- Antigens, CD44
- Hyaluronan Receptor
- Receptor, Hyaluronan
- Chondroitin Sulfate Proteoglycan 8
- CD44 Antigens
|
Below are MeSH descriptors whose meaning is more general than "Hyaluronan Receptors".
Below are MeSH descriptors whose meaning is more specific than "Hyaluronan Receptors".
This graph shows the total number of publications written about "Hyaluronan Receptors" by people in this website by year, and whether "Hyaluronan Receptors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hyaluronan Receptors" by people in Profiles.
-
Pach?n-Pe?a G, Donnelly C, Ruiz-Ca?ada C, Katz A, Fern?ndez-Veledo S, Vendrell J, Sackstein R. A Glycovariant of Human CD44 is Characteristically Expressed on Human Mesenchymal Stem Cells. Stem Cells. 2017 04; 35(4):1080-1092.
-
Goel HL, Gritsko T, Pursell B, Chang C, Shultz LD, Greiner DL, Norum JH, Toftgard R, Shaw LM, Mercurio AM. Regulated splicing of the a6 integrin cytoplasmic domain determines the fate of breast cancer stem cells. Cell Rep. 2014 May 08; 7(3):747-61.
-
Loh TJ, Moon H, Cho S, Jung DW, Hong SE, Kim DH, Green MR, Zheng X, Zhou J, Shen H. SC35 promotes splicing of the C5-V6-C6 isoform of CD44 pre-mRNA. Oncol Rep. 2014 Jan; 31(1):273-9.
-
Egan CE, Daugherity EK, Rogers AB, Abi Abdallah DS, Denkers EY, Maurer KJ. CCR2 and CD44 promote inflammatory cell recruitment during fatty liver formation in a lithogenic diet fed mouse model. PLoS One. 2013; 8(6):e65247.
-
Patel SA, Ramkissoon SH, Bryan M, Pliner LF, Dontu G, Patel PS, Amiri S, Pine SR, Rameshwar P. Delineation of breast cancer cell hierarchy identifies the subset responsible for dormancy. Sci Rep. 2012; 2:906.
-
Cachia D, Alderson L, Smith T, Yunus S. Widely metastatic meningioma. Arch Neurol. 2012 Oct; 69(10):1372-3.
-
Atherly LO, Lucas JA, Felices M, Yin CC, Reiner SL, Berg LJ. The Tec family tyrosine kinases Itk and Rlk regulate the development of conventional CD8+ T cells. Immunity. 2006 Jul; 25(1):79-91.
-
Trimble LA, Prince KA, Pestano GA, Daley J, Cantor H. Fas-dependent elimination of nonselected CD8 cells and lpr disease. J Immunol. 2002 May 15; 168(10):4960-7.
-
Tucker AS, Al Khamis A, Ferguson CA, Bach I, Rosenfeld MG, Sharpe PT. Conserved regulation of mesenchymal gene expression by Fgf-8 in face and limb development. Development. 1999 Jan; 126(2):221-8.